THE INTELLECTUAL HEALTH OF CLINICAL DRUG-EVALUATION

被引：62
作者：
SHEINER, LB
机构：
[1] UNIV CALIF SAN FRANCISCO,SCH MED,DEPT MED,SAN FRANCISCO,CA 94143
[2] UNIV CALIF SAN FRANCISCO,SCH PHARM,DEPT PHARM,SAN FRANCISCO,CA 94143
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1991年 / 50卷 / 01期
关键词：
D O I：
10.1038/clpt.1991.97
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：4 / 9
页数：6
相关论文
共 29 条
  • [1] Beal S, 1989, NONMEM USERS GUIDES
  • [2] BEAL SL, 1982, CRIT REV BIOMED ENG, V8, P195
  • [3] ELIGIBILITY AND EXTRAPOLATION IN CANCER CLINICAL-TRIALS
    BEGG, CB
    ENGSTROM, PF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (06) : 962 - 968
  • [4] BERGER JO, 1988, AM SCI, V76, P159
  • [5] CONFIDENCE-INTERVALS EXTRACT CLINICALLY USEFUL INFORMATION FROM DATA
    BRAITMAN, LE
    [J]. ANNALS OF INTERNAL MEDICINE, 1988, 108 (02) : 296 - 298
  • [6] Breslow N., 1990, STAT SCI, V5, P269
  • [7] HOW OFTEN IS MEDICATION TAKEN AS PRESCRIBED - A NOVEL ASSESSMENT TECHNIQUE
    CRAMER, JA
    MATTSON, RH
    PREVEY, ML
    SCHEYER, RD
    OUELLETTE, VL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (22): : 3273 - 3277
  • [8] Efron B., 1986, STAT SCI, P54, DOI DOI 10.1214/SS/1177013815
  • [9] USING PERMUTATION TESTS AND BOOTSTRAP CONFIDENCE-LIMITS TO ANALYZE REPEATED EVENTS DATA FROM CLINICAL-TRIALS
    FREEDMAN, L
    SYLVESTER, R
    BYAR, DP
    [J]. CONTROLLED CLINICAL TRIALS, 1989, 10 (02): : 129 - 141
  • [10] ISSUES IN THE DESIGN OF DRUG TRIALS FOR AIDS
    GREEN, SB
    ELLENBERG, SS
    FINKELSTEIN, D
    FORSYTHE, AB
    FREEDMAN, LS
    FREEMAN, K
    LEFKOPOULOU, M
    SCHOENFELD, D
    SMITH, RP
    [J]. CONTROLLED CLINICAL TRIALS, 1990, 11 (02): : 80 - 87
123